|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
SCIDIR_on1003268037 |
| 003 |
OCoLC |
| 005 |
20231120010215.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
170824t20172018enk ob 001 0 eng d |
| 040 |
|
|
|a NLE
|b eng
|e rda
|e pn
|c NLE
|d IDEBK
|d YDX
|d N$T
|d EBLCP
|d OPELS
|d OCLCF
|d MERER
|d GZM
|d TXM
|d OCLCQ
|d OTZ
|d ESU
|d UPM
|d OCLCO
|d OCLCA
|d COO
|d D6H
|d DKU
|d OCLCO
|d OCL
|d OCLCO
|d U3W
|d OCLCO
|d MERUC
|d OCLCO
|d OCLCQ
|d WYU
|d OCLCA
|d CNCGM
|d OCLCO
|d UKMGB
|d OCLCQ
|d OCLCO
|d OCLCA
|d OCLCQ
|d S2H
|d OCLCO
|d OCLCQ
|d VT2
|d OCLCQ
|d OCLCO
|d OCL
|d OCLCQ
|d CASUM
|d SFB
|d OCLCO
|
| 066 |
|
|
|c (S
|
| 015 |
|
|
|a GBB7F3144
|2 bnb
|
| 016 |
7 |
|
|a 101718244
|2 DNLM
|
| 016 |
7 |
|
|a 018484053
|2 Uk
|
| 019 |
|
|
|a 1002191584
|a 1002209823
|a 1002422816
|a 1005688704
|a 1006809024
|a 1007404307
|a 1008646550
|a 1016406368
|a 1066456504
|a 1088211771
|a 1235827470
|
| 020 |
|
|
|a 9780128051832
|q (ePub ebook)
|
| 020 |
|
|
|a 0128051833
|q (ePub ebook)
|
| 020 |
|
|
|z 9780128047910
|q (pbk.)
|
| 020 |
|
|
|z 0128047917
|
| 035 |
|
|
|a (OCoLC)1003268037
|z (OCoLC)1002191584
|z (OCoLC)1002209823
|z (OCoLC)1002422816
|z (OCoLC)1005688704
|z (OCoLC)1006809024
|z (OCoLC)1007404307
|z (OCoLC)1008646550
|z (OCoLC)1016406368
|z (OCoLC)1066456504
|z (OCoLC)1088211771
|z (OCoLC)1235827470
|
| 050 |
|
4 |
|a QP801.C27
|
| 060 |
|
4 |
|a 2017 I-844
|
| 060 |
|
4 |
|a WM 203
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 613.835
|2 23
|
| 245 |
0 |
4 |
|a The complex connection between cannabis and schizophrenia /
|c edited by Michael T. Compton, Marc W. Manseau.
|
| 264 |
|
1 |
|a London :
|b Academic Press,
|c [2017]
|
| 264 |
|
4 |
|c �2018
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Front Cover; The Complex Connection between Cannabis and Schizophrenia; Copyright; Contents; Contributors; Chapter 1: An Introduction to the Complex Connection Between Cannabis and Schizophrenia; Background and History; Cannabis and Psychosis; Brief Overview of the Book; Conclusions; References; Chapter 2: The Epidemiology of Cannabis Use in the United States*; Introduction; Data Sources and Methods; Data Sources; Measures; Statistical Analyses; Epidemiology of Cannabis Use and Use Disorders Among Youth; Trends in Cannabis, Tobacco, and Alcohol Use Among Youth.
|
| 505 |
8 |
|
|a Trends in Risk Perceptions of Smoking Cannabis and Perceived Cannabis Availability Among YouthTrends in Cannabis Use Disorders and Perceived Risk of Smoking Cannabis Among Youth Cannabis Users; Trends in and Associations of Cannabis Use Among Youth Tobacco and Alcohol Users; Other Correlates of Cannabis Use and Use Disorders Among Youth; Implications of Trends and Correlates of Cannabis Use Among Youth; Epidemiology of Cannabis Use and Use Disorders Among Adults; Trends in Cannabis Use, Use Disorders, and Use Frequency Among Adults and Adult Users.
|
| 505 |
8 |
|
|a Associations Between Trends in Cannabis Use, Use Disorders, Use Frequency, and Perceived Risk of Smoking Cannabis Among Adu ... Other Correlates of Cannabis Use and Use Disorders Among Adults; Implications of Trends and Correlates of Cannabis Use and Use Disorders Among Adults; Needed Research; References; Chapter 3: Cannabinoids and the Brain: The Effects of Endogenous and Exogenous Cannabinoids on Brain Systems and Function; Introduction; The Biology of the Endocannabinoid System; Endogenous Ligands; CB1 Receptors; CB2 Receptors; TRPV and Other Receptors.
|
| 505 |
8 |
|
|a Mechanisms of Endocannabinoid Transmission2-Arachidonoylglycerol; 2-AG Metabolism; Anandamide; AEA Metabolism; Neuroplastic Changes Induced by Cannabinoids; Depolarization-Induced Sustained Inhibition or Excitation; Long-Term Potentiation or Depression; Endocannabinoids and Psychosis; Mechanisms of Psychosis and the Effects of Cannabinoids; Perception and Psychosis; Dopamine, Cannabinoids, and Schizophrenia; Endocannabinoids, Psychosis, and Perception and Understanding of Self; Shared Biomarkers of Schizophrenia and Cannabinoid Activity; Prefrontal Cortex Anomalies.
|
| 505 |
8 |
|
|a Interindividual Vulnerability to Cannabis-Induced PsychosisPsychosis and Cannabis: Intersection in the Hippocampus; A Working Model of Cannabis-Induced Psychosis Based on Declarative Memory Dysfunction; Effects of Cannabis on the Hippocampus and the Relationship to Schizophrenia; Summarizing a Working Model; Cannabinoids and Psychosis: Neuropsychological Constructs; Cannabis, Mood and Affect, and Psychosis; Endocannabinoids, Cannabis, Reward Processing, and Psychosis; Cannabis, Psychosis, and Salience; Cannabis, Psychosis, Attention, and Cognition.
|
| 650 |
|
0 |
|a Marijuana abuse
|x Health aspects.
|
| 650 |
|
0 |
|a Schizophrenia.
|
| 650 |
|
0 |
|a Psychopharmacology.
|
| 650 |
1 |
2 |
|a Schizophrenia
|x etiology
|0 (DNLM)D012559Q000209
|
| 650 |
1 |
2 |
|a Schizophrenia
|x drug therapy
|0 (DNLM)D012559Q000188
|
| 650 |
2 |
2 |
|a Cannabinoids
|x adverse effects
|0 (DNLM)D002186Q000009
|
| 650 |
2 |
2 |
|a Cannabinoids
|x therapeutic use
|0 (DNLM)D002186Q000627
|
| 650 |
2 |
2 |
|a Medical Marijuana
|x pharmacology
|0 (DNLM)D064086Q000494
|
| 650 |
2 |
2 |
|a Psychopharmacology
|0 (DNLM)D011600
|
| 650 |
|
2 |
|a Schizophrenic Psychology
|0 (DNLM)D012565
|
| 650 |
|
2 |
|a Schizophrenia
|0 (DNLM)D012559
|
| 650 |
|
6 |
|a Schizophr�enie.
|0 (CaQQLa)201-0020959
|
| 650 |
|
6 |
|a Psychopharmacologie.
|0 (CaQQLa)201-0020955
|
| 650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
| 650 |
|
7 |
|a Psychopharmacology
|2 fast
|0 (OCoLC)fst01081659
|
| 650 |
|
7 |
|a Schizophrenia
|2 fast
|0 (OCoLC)fst01106752
|
| 655 |
|
0 |
|a Electronic books.
|
| 655 |
|
4 |
|a Internet Resources.
|
| 655 |
|
4 |
|a Charts.
|
| 700 |
1 |
|
|a Compton, Michael T.,
|e editor.
|
| 700 |
1 |
|
|a Manseau, Marc,
|e editor.
|
| 776 |
0 |
8 |
|i Print version :
|z 9780128047910
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128047910
|z Texto completo
|
| 880 |
0 |
|
|6 505-00/(S
|a An Introduction to the Complex Connection Between Cannabis and Schizophrenia -- The Epidemiology of Cannabis Use in the United States -- Cannabinoids and the Brain: The Effects of Endogenous and Exogenous Cannabinoids on Brain Systems and Function -- Psychotomimetic and Cognitive Effects of Δ9-Tetrahydrocannabinol in Laboratory Settings -- Psychotomimetic and Cognitive Effects of Cannabis Use in the General Population -- The Association Between Cannabis Use and Schizotypy -- Effects of Cannabis Use in Those at Ultra-High Risk for Psychosis -- Cannabis-Induced Psychotic Disorders -- Synthetic Cannabinoids and Synthetic Cannabinoid-Induced Psychotic Disorders -- Cannabis Use as an Independent Risk Factor for, or Component Cause of, Schizophrenia and Related Psychotic Disorders -- Cannabis Use as a Determinant of Earlier Age at Onset of Schizophrenia and Related Psychotic Disorders -- The Prevalence and Effects of Cannabis Use Among Individuals With Schizophrenia and Related Psychotic Disorders -- The Treatment of Cannabis Use Disorder Among Individuals With a Psychotic Disorder -- Cannabidiol as a Potential Novel Therapeutic Agent for Psychotic Disorders.
|
